Inspiraâ„¢ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that on March 10, 2025, the Company ...
Inspira Technologies (IINN) announced positive results from the clinical study of its AI-powered HYLA blood sensor. The HYLA achieved 96% ...
9don MSN
Inspira Technologies' HYLA blood sensor achieves 96% accuracy in clinical study, paving the way for FDA submission by 2025.
Inspiraâ„¢ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced positive results from the clinical ...
The clinical study involved 6 patients undergoing open-heart surgery with the clip-on HYLA blood sensor attached at two different points on the blood circuit tubing, allowing monitoring of the ...
The Company is proud to report that the HYLA successfully achieved 96% accuracy in its clinical study results for a key parameter, as compared to traditional blood test analyzers. In addition ...
Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd.
Inspira Technologies (NASDAQ:IINN) announced, on Tuesday, positive results from the clinical study of its AI-powered HYLA blood sensor. The company reported that the HYLA successfully achieved 96% ...
Inspira Technologies' innovative blood sensor is gaining attention. According to a recent announcement, results from the ...
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results